APP and neoplasm: The compound of APP and death receptor 6 (DR6/TNFRSF21) inhibited the activation of necroptosis of vascular endothelial cells, resulting in significant reduction in transdermal migration of tumor cells, thus controlling tumor metastasis (Wang et al., 2021).